Biomarcadores sanguíneos diferenciales de las dimensiones psicopatológicas de la esquizofrenia-Reference-Cited by-同舟云学术

Biomarcadores sanguíneos diferenciales de las dimensiones psicopatológicas de la esquizofrenia

Published:2016-10 Issue:4 Volume:9 Page:219-227
ISSN:1888-9891
Container-title:Revista de Psiquiatría y Salud Mental
language:es
Short-container-title:Revista de Psiquiatría y Salud Mental

Author:

Garcia-Alvarez Leticia,Garcia-Portilla Maria Paz,Gonzalez-Blanco Leticia,Saiz Martinez Pilar Alejandra,de la Fuente-Tomas Lorena,Menendez-Miranda Isabel,Iglesias Celso,Bobes Julio

Publisher

Elsevier BV

Subject

Psychiatry and Mental health

Reference117 articles.

1. Schizophrenia;Van Os;Lancet.,2009

2. The size and burden of mental disorders and other disorders of the brain in Europe 2010;Wittchen;Eur Neuropsychopharmacol.,2011

3. Applications of blood-based protein biomarker strategies in the study of psychiatric disorders;Chan;Progr Neurobiol.,2014

4. The NIMH Research Domain Criteria (RDoC) Project: Precision medicine for psychiatry;Insel;Am J Psychiatry.,2014

5. Scale for the Assessment of Positive Symptoms;Andreasen,1984

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV-Associated Neurocognitive Disorder: A Look into Cellular and Molecular Pathology;International Journal of Molecular Sciences;2024-04-25

2. Executive function and decision-making in Colombian patients with paranoid schizophrenia;F1000Research;2024-03-11

3. Correlation between elevated serum interleukin-1β, interleukin-16 levels and psychiatric symptoms in patients with schizophrenia at different stages;BMC Psychiatry;2023-06-03

4. Different measures for auditory hallucinations in populations with psychosis. The Validation of the Spanish versions of the Auditory Vocal Hallucination Rating Scale (AVHRS) and the Positive and Useful Voices Inquiry (PUVI);Revista de Psiquiatría y Salud Mental (English Edition);2022-10

5. Recent advancements in biomarker research in schizophrenia: mapping the road from bench to bedside;Metabolic Brain Disease;2022-03-03